Clinical Trial

Effects of Cervical Mobilization on Dizziness, Balance, and Joint Position Sense in Patients With Meniere's Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 19, 2025 (before its estimated March 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study will employ a stratified randomization method. Patients presenting to the Afyonkarahisar Health Sciences University Health Application and Research Center, Ear, Nose, and Throat Outpatient Clinic, with a definitive diagnosis of Meniere's disease, unilateral or bilateral involvement, and who consent to participate in the study will be divided into three groups. The control group will receive only their routine Betahistine. Their usual treatment will remain unchanged. The first study group will receive 20 minutes of Vestibular Rehabilitation (VR) and 10 minutes of cervical mobilization in addition to their routine Betahistine. The second study group will receive 30 minutes of VR in addition to Betahistine. The study will last 6 weeks. Participants will be assessed using a sociodemographic information questionnaire, the Dizziness Handicap Inventory (DHI), the Vertigo Symptom Scale (VSS), the Neck Disability Index (NDI), the International Tinnitus Inventory (ITI), balance assessment with the K-Force Plates, and joint position sense and proprioception assessment with the Kinvent Physio K-Move. All assessments will be conducted twice, before and after treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-27.
Trial Details
NCT Number NCT07272473
Lead Sponsor Abant Izzet Baysal University
Conditions Meniere Disease
Enrollment 33 participants
Start Date 2025-09-20
Primary Completion 2026-03-30 (estimated)
Study Completion 2026-05-05 (estimated)
Updated on ClinicalTrials.gov 2025-12-19